about
Role of Vanadium in Cellular and Molecular Immunology: Association with Immune-Related Inflammation and Pharmacotoxicology MechanismsWater soluble, cyclometalated Pt(ii)-Ln(iii) conjugates towards novel bimodal imaging agents.In Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles.Cytotoxicity of Pyrazine-Based Cyclometalated (C^Npz^C)Au(III) Carbene Complexes: Impact of the Nature of the Ancillary Ligand on the Biological Properties.Carcinogenic Chromium(VI) Compounds Formed by Intracellular Oxidation of Chromium(III) Dietary Supplements by Adipocytes.Reactivity-activity relationships of oral anti-diabetic vanadium complexes in gastrointestinal media: an X-ray absorption spectroscopic study.Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complexMetal and metalloid containing natural products and a brief overview of their applications in biology, biotechnology and biomedicine.Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60.Targeting of DNA molecules, BSA/c-Met tyrosine kinase receptors and anti-proliferative activity of bis(terpyridine)copper(ii) complexes.Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor CellsDeveloping an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer.Metal complexes and metalloproteases: targeting conformational diseases.Current and potential applications of bismuth-based drugs.Gold(III) complexes in medicinal chemistry.Metal complex interactions with DNA.Synthesis, Characterization, Cytotoxic Activity, and Interactions with CT-DNA and BSA of Cationic Ruthenium(II) Complexes Containing Dppm and Quinoline CarboxylatesRuthenium-based nitric oxide-donating and carbon monoxide-donating molecules.Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?Structurally related hydrazone-based metal complexes with different antitumor activities variably induce apoptotic cell death.Interstrand DNA covalent binding of two dinuclear Ru(ii) complexes. Influence of the extra ring of the bridging ligand on the DNA interaction and cytotoxic activity.Synergistic Antimicrobial Effects of Silver/Transition-metal Combinatorial Treatments.Studies on Photocleavage, DNA Binding, Cytotoxicity, and Docking Studies of Ruthenium(II) Mixed Ligand Complexes.Copper(II) complexes with naringenin and hesperetin: cytotoxic activity against A 549 human lung adenocarcinoma cells and investigation on the mode of action.Sugar-boronate ester scaffold tethered pyridyl-imine palladium(II) complexes: synthesis and their in vitro anticancer evaluation.Silica-coated bismuth sulfide nanorods as multimodal contrast agents for a non-invasive visualization of the gastrointestinal tract.Two novel BODIPY-Ru(ii) arene dyads enabling effective photo-inactivation against cancer cells.Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C^N theme.Biologically active [Pd2L4](4+) quadruply-stranded helicates: stability and cytotoxicity.Efficient one-pot synthesis of trans-Pt(II)(salicylaldimine)(4-picoline)Cl complexes: effective agents for enhanced expression of p53 tumor suppressor genes.Re(I) and Tc(I) complexes for targeting nitric oxide synthase: influence of the chelator in the affinity for the enzyme.Photoswitching the cytotoxic properties of platinum(II) compounds.Synthesis and anticancer activities of a novel class of mono- and di-metallic Pt(II)(salicylaldiminato)(DMSO or Picolino)Cl complexes.Towards the elaboration of new gold-based optical theranostics.Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity.Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.Designing metallodrugs with nuclease and protease activity.Recent developments in gold(I) coordination chemistry: luminescence properties and bioimaging opportunities.Visualization of metallodrugs in single cells by secondary ion mass spectrometry imaging.Bone-seeking agents for the treatment of bone disorders.
P2860
Q26748760-4184101F-EB58-4243-AC10-56306928C507Q30978325-722DAB9D-380F-496A-A335-54F358A9AA42Q31148784-F60F2E3F-F50F-45FC-87C9-D31D9578268CQ33696556-8E550D65-25F3-4175-8D90-0D59988E11A3Q34506295-26748568-1417-4F47-8E90-31DE6087B126Q35220583-FB87B12D-4696-4207-AF7D-102FAEF54173Q35805471-03BC6EF7-DF71-4309-BE5F-E05EA34D8E3FQ35836648-F1949819-D3AF-4519-AEA4-C1B716BB10BDQ35867952-90C8D9DB-077A-41C6-B77F-08DFB631A8A6Q35985323-C56258C6-7B88-439B-BE3B-E42CC27A97C7Q36499563-EEC9C21B-4DD2-48F3-AA9E-245096702F14Q37687110-D981B9BD-3D94-46F4-A7B8-9A1A03AFEBEBQ38215608-1F364E4A-9CDC-46D2-9CB6-94F3F3272114Q38253836-4B6A7E3F-27C4-4015-A252-3153394B48F9Q38264535-3EF88D73-89ED-41EC-9FC2-356B66B128FEQ38271731-E0B65C31-29FC-4E50-8408-BC5305F8D399Q38621306-4A03A76D-DBFD-4575-B4BD-23DE91C76CA1Q38698568-00E8C13D-E451-4371-9367-400D57C4BAC8Q38710506-78DECF02-72DE-4013-9FD4-03291BA1DF7DQ38710830-E6FBF6F6-7FF2-4C30-994D-715117FB7167Q38714551-8FE3B1C7-044B-443B-BD6E-80D801B5008AQ38728622-8AFA5CC8-E43C-491C-A0AD-B2A5EBBBC042Q38735217-44C4A206-9B85-4ABB-ADEB-EA53D5C99B1FQ38818579-6D82AB1D-CD71-4FC4-8B82-67E7ABA4F229Q38833511-12F0290A-D072-4BA1-862E-862DF890A36FQ38856497-C670EFD9-B768-42AA-AB74-193268F9352FQ38862566-ED3C03D0-B0FC-4106-AE67-54E584C00E31Q38865464-F02A8CC3-446F-43AF-A33A-C30BB4D6B432Q38872477-8FF39252-8EA0-4E04-B232-F0FB65B293E1Q38879218-A7B06545-7AD3-4E0A-94A6-28A3DF00A0ABQ38884546-C4FAAF1A-62B2-479E-BAD8-186EDE2EA153Q38908754-4B61E326-C42D-48E6-919A-84DB0D518202Q38928386-69434C52-F86C-4649-AB86-7148AA719447Q38930321-94990887-B01E-4053-99D6-2CC6A4BA9932Q38951818-B00E9857-0884-4629-829B-A0BC39A461B3Q38962540-3895A0A8-1FD4-4474-9DA3-889CB2A678FFQ38974558-8AAEFA5D-781C-40BF-9057-3C87F76D5CC5Q38984457-506D7FF8-D5B2-4852-8E2E-6EADB04D76A5Q39309141-6919F194-772A-4274-A671-AF7C0895B3DCQ39356298-77630F4C-583D-47AE-A923-635180EFD434
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metallodrugs in medicinal inorganic chemistry
@ast
Metallodrugs in medicinal inorganic chemistry
@en
Metallodrugs in medicinal inorganic chemistry
@nl
type
label
Metallodrugs in medicinal inorganic chemistry
@ast
Metallodrugs in medicinal inorganic chemistry
@en
Metallodrugs in medicinal inorganic chemistry
@nl
prefLabel
Metallodrugs in medicinal inorganic chemistry
@ast
Metallodrugs in medicinal inorganic chemistry
@en
Metallodrugs in medicinal inorganic chemistry
@nl
P356
P1433
P1476
Metallodrugs in medicinal inorganic chemistry
@en
P2093
Chris Orvig
Katja Dralle Mjos
P304
P356
10.1021/CR400460S
P407
P577
2014-04-23T00:00:00Z